NRC HEALTH (NRC) Fundamental Analysis & Valuation

NASDAQ:NRC • US6373722023

Current stock price

16.84 USD
-0.27 (-1.58%)
At close:
16.84 USD
0 (0%)
After Hours:

This NRC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. NRC Profitability Analysis

1.1 Basic Checks

  • In the past year NRC was profitable.
  • In the past year NRC had a positive cash flow from operations.
  • In the past 5 years NRC has always been profitable.
  • NRC had a positive operating cash flow in each of the past 5 years.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • NRC has a Return On Assets of 8.37%. This is amongst the best in the industry. NRC outperforms 93.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 80.72%, NRC belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
  • The Return On Invested Capital of NRC (16.19%) is better than 94.00% of its industry peers.
  • NRC had an Average Return On Invested Capital over the past 3 years of 24.89%. This is significantly above the industry average of 8.40%.
  • The 3 year average ROIC (24.89%) for NRC is well above the current ROIC(16.19%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.37%
ROE 80.72%
ROIC 16.19%
ROA(3y)17.45%
ROA(5y)20.09%
ROE(3y)74.39%
ROE(5y)62.24%
ROIC(3y)24.89%
ROIC(5y)29.78%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

1.3 Margins

  • NRC has a better Profit Margin (8.22%) than 90.00% of its industry peers.
  • NRC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.45%, NRC belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
  • NRC's Operating Margin has declined in the last couple of years.
  • NRC's Gross Margin of 61.88% is amongst the best of the industry. NRC outperforms 83.00% of its industry peers.
  • NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.45%
PM (TTM) 8.22%
GM 61.88%
OM growth 3Y-25.58%
OM growth 5Y-12.28%
PM growth 3Y-26.82%
PM growth 5Y-21.69%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NRC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.
  • The number of shares outstanding for NRC has been reduced compared to 1 year ago.
  • NRC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NRC is higher compared to a year ago.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.15 indicates that NRC is not in any danger for bankruptcy at the moment.
  • NRC's Altman-Z score of 3.15 is fine compared to the rest of the industry. NRC outperforms 70.00% of its industry peers.
  • NRC has a debt to FCF ratio of 5.02. This is a neutral value as NRC would need 5.02 years to pay back of all of its debts.
  • NRC has a Debt to FCF ratio (5.02) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 5.36 is on the high side and indicates that NRC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 5.36, NRC is doing worse than 79.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Altman-Z 3.15
ROIC/WACC1.86
WACC8.69%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • NRC has a Current Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.55, NRC is doing worse than 90.00% of the companies in the same industry.
  • NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NRC's Quick ratio of 0.55 is on the low side compared to the rest of the industry. NRC is outperformed by 86.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NRC Growth Analysis

3.1 Past

  • NRC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • The Earnings Per Share has been growing slightly by 3.24% on average over the past years.
  • The Revenue has decreased by -1.99% in the past year.
  • Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 4.42% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%3.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

3

4. NRC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.47, NRC is valued correctly.
  • NRC's Price/Earnings ratio is rather cheap when compared to the industry. NRC is cheaper than 86.00% of the companies in the same industry.
  • NRC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.47
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NRC's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 24.33
EV/EBITDA 15.16
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.16
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NRC Dividend Analysis

5.1 Amount

  • NRC has a Yearly Dividend Yield of 3.74%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.46, NRC pays a better dividend. On top of this NRC pays more dividend than 98.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

  • The dividend of NRC has a limited annual growth rate of 2.80%.
  • NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NRC has decreased its dividend recently.
Dividend Growth(5Y)2.8%
Div Incr Years1
Div Non Decr Years1
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • NRC pays out 97.21% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of NRC is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP97.21%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NRC Fundamentals: All Metrics, Ratios and Statistics

NRC HEALTH

NASDAQ:NRC (4/28/2026, 8:00:02 PM)

After market: 16.84 0 (0%)

16.84

-0.27 (-1.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.69
Industry Growth87.58
Earnings (Last)04-28
Earnings (Next)N/A
Inst Owners48.16%
Inst Owner Change0%
Ins Owners10.65%
Ins Owner Change1.04%
Market Cap383.11M
Revenue(TTM)148.58M
Net Income(TTM)11.29M
Analysts45
Price TargetN/A
Short Float %3.61%
Short Ratio4.53
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP97.21%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.47
Fwd PE N/A
P/S 2.79
P/FCF 24.33
P/OCF 14.48
P/B 27.38
P/tB N/A
EV/EBITDA 15.16
EPS(TTM)1.25
EY7.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY4.11%
OCF(TTM)1.16
OCFY6.9%
SpS6.04
BVpS0.61
TBVpS-2.39
PEG (NY)N/A
PEG (5Y)4.16
Graham Number4.15877 (-75.3%)
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 80.72%
ROCE 23%
ROIC 16.19%
ROICexc 16.91%
ROICexgc 61.81%
OM 16.45%
PM (TTM) 8.22%
GM 61.88%
FCFM 11.46%
ROA(3y)17.45%
ROA(5y)20.09%
ROE(3y)74.39%
ROE(5y)62.24%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.44%
ROICexc(5y)39.02%
ROICexgc(3y)112.69%
ROICexgc(5y)N/A
ROCE(3y)35.36%
ROCE(5y)42.3%
ROICexgc growth 3Y-49.45%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.54%
OM growth 3Y-25.58%
OM growth 5Y-12.28%
PM growth 3Y-26.82%
PM growth 5Y-21.69%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Debt/EBITDA 2.48
Cap/Depr 140.43%
Cap/Sales 7.79%
Interest Coverage 5.04
Cash Conversion 87.52%
Profit Quality 139.41%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 3.15
F-Score6
WACC8.69%
ROIC/WACC1.86
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)96.31%
Profit Quality(5y)96.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%3.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.67%
EBIT growth 3Y-27.98%
EBIT growth 5Y-11.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%

NRC HEALTH / NRC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NRC HEALTH (NRC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NRC.


Can you provide the valuation status for NRC HEALTH?

ChartMill assigns a valuation rating of 3 / 10 to NRC HEALTH (NRC). This can be considered as Overvalued.


How profitable is NRC HEALTH (NRC) stock?

NRC HEALTH (NRC) has a profitability rating of 8 / 10.


Can you provide the dividend sustainability for NRC stock?

The dividend rating of NRC HEALTH (NRC) is 5 / 10 and the dividend payout ratio is 97.21%.